Ceja-Gálvez, H.R.; Renteria-Flores, F.I.; Nicoletti, F.; Hernández-Bello, J.; Macedo-Ojeda, G.; Muñoz-Valle, J.F.
Severe COVID-19: Drugs and Clinical Trials. J. Clin. Med. 2023, 12, 2893.
https://doi.org/10.3390/jcm12082893
AMA Style
Ceja-Gálvez HR, Renteria-Flores FI, Nicoletti F, Hernández-Bello J, Macedo-Ojeda G, Muñoz-Valle JF.
Severe COVID-19: Drugs and Clinical Trials. Journal of Clinical Medicine. 2023; 12(8):2893.
https://doi.org/10.3390/jcm12082893
Chicago/Turabian Style
Ceja-Gálvez, Hazael Ramiro, Francisco Israel Renteria-Flores, Ferdinando Nicoletti, Jorge Hernández-Bello, Gabriela Macedo-Ojeda, and José Francisco Muñoz-Valle.
2023. "Severe COVID-19: Drugs and Clinical Trials" Journal of Clinical Medicine 12, no. 8: 2893.
https://doi.org/10.3390/jcm12082893
APA Style
Ceja-Gálvez, H. R., Renteria-Flores, F. I., Nicoletti, F., Hernández-Bello, J., Macedo-Ojeda, G., & Muñoz-Valle, J. F.
(2023). Severe COVID-19: Drugs and Clinical Trials. Journal of Clinical Medicine, 12(8), 2893.
https://doi.org/10.3390/jcm12082893